Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126885501 | 12688550 | 1 | I | 20160815 | 0 | 20160825 | 20160825 | DIR | 48.00 | YR | F | N | 131.00000 | LBS | 20160824 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126885501 | 12688550 | 1 | PS | KLONOPIN | CLONAZEPAM | 1 | Oral | 60 TABLETS TWICE A DAY | Y | Y | 0 | 60 | DF | COATED TABLET | BID | ||||
| 126885501 | 12688550 | 3 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126885501 | 12688550 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126885501 | 12688550 | 7 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126885501 | 12688550 | 1 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126885501 | 12688550 | Depression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126885501 | 12688550 | 1 | 20160712 | 20160815 | 0 |